The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil.
de Lemos LLP, Guerra Júnior AA, Santos M, Magliano C, Diniz I, Souza K, Pereira RG, Alvares J, Godman B, Bennie M, Zimmermann IR, Dos Santos VCC, Pretramale CA, Acurcio FA.
de Lemos LLP, et al. Among authors: zimmermann ir.
Pharmacoeconomics. 2018 Feb;36(2):161-173. doi: 10.1007/s40273-017-0579-0.
Pharmacoeconomics. 2018.
PMID: 29139001
Free PMC article.
Review.